**Executive Summary**
The 9th edition of India Pharma 2026 is scheduled for April 13–14, 2026, at Federation House, New Delhi. Organized by the Department of Pharmaceuticals in association with FICCI and the Indian Pharmaceutical Alliance (IPA), the event aims to transition India into a global pharmaceutical innovation hub. The conference will focus on research and development (R&D), supply chain resilience, and the theme "Discover in India: Leapfrogging Life-Sciences Innovation."
**Key Points / Main Content**
**Event Overview and Objectives**
* **Purpose:** To serve as a platform for sectoral growth, international collaboration, and the transition from a volume-driven to a value- and innovation-led pharmaceutical model.
* **Strategic Vision:** Aligned with "Viksit Bharat 2047," the event supports "Atma Nirbharta" (self-reliance) through policy interventions and industry-academia partnerships.
* **Core Components:** The event includes a CEO’s Roundtable, Plenary Conference Sessions, a Thematic Exhibition, and a Startup Showcase Session.
**Plenary Session Themes**
* **Innovation and Policy:** Focusing on policy thrusts for catalysing innovation and enabling regulatory ecosystems.
* **Technology and R&D:** Harnessing AI and next-gen technologies for disruptive innovation and unleashing India’s Contract Research, Development, and Manufacturing Organization (CRDMO) potential.
* **Finance and Future Growth:** Developing a vibrant pharma financing ecosystem and discussing "Big Moves" to leapfrog innovation.
**Leadership and Participation**
* **Government Representation:** Inauguration by the Union Minister and Minister of State for Chemicals & Fertilizers, with participation from NITI Aayog and the Ministry of Health & Family Welfare.
* **Regulatory Insights:** Perspectives provided by the Drug Controller General of India (DCGI), CDSCO, and the US FDA.
* **Industry Presence:** Participation from leaders of major firms including Sun Pharma, Zydus Lifesciences, Mankind Pharma, Cipla, Eli Lilly, and Abbott India.
**Impact Analysis**
**Pharmaceutical Industry Leaders**
**Impact**
The event provides a platform to influence global supply chains and transition toward high-value innovation.
**Action Required**
Engage in the CEO’s Roundtable and plenary sessions to align business strategies with national innovation goals.
**Startups and Innovators**
**Impact**
Startups gain visibility through a dedicated showcase session and access to discussions on the pharma financing ecosystem.
**Action Required**
Utilize the "Start-up Showcase" to present disruptive technologies and seek potential investment or partnerships.
**Regulators (DCGI, CDSCO, US FDA)**
**Impact**
Regulators are tasked with fostering an ecosystem that balances safety with the need for rapid innovation.
**Action Required**
Participate in sessions dedicated to "Enabling Regulatory Ecosystems" to provide domestic and global regulatory clarity.
**Policymakers**
**Impact**
The event serves as a forum to refine policy interventions and infrastructure development for the medtech and pharma sectors.
**Action Required**
Collate industry feedback to drive "Atma Nirbharta" and strengthen industry-academia collaborations.
Key Entities Referenced
India Pharma 2026: The 9th edition of the flagship pharmaceutical event focused on sectoral innovation and India's transition into a global pharma innovation hub.
Department of Pharmaceuticals: The nodal government department under the Ministry of Chemicals and Fertilizers responsible for organizing the event and driving pharmaceutical policy interventions.
Federation of Indian Chambers of Commerce and Industry (FICCI): India's apex business organization acting as the primary industry partner and host for the landmark Life-Sciences Dialogue.
Viksit Bharat 2047: The strategic national vision for a developed India, providing the long-term policy framework for sector growth and international collaboration.
Ministry of Chemicals and Fertilizers :
Department of Pharmaceuticals
India Pharma 2026 to be held on April 13–14 in
New Delhi, showcasing Sectoral Innovation
Policymakers and Global Pharma Leaders to convene for
landmark Life-Sciences Dialogue
9th Edition of India Pharma 2026 to Drive India’s Transition to
a Global Pharma Innovation Hub
Posted On: 11 APR 2026 3:08PM by PIB Delhi
The Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India, is
organising the 9th edition of India Pharma 2026. The event is being held in association with the
Federation of Indian Chambers of Commerce and Industry (FICCI) and the Indian Pharmaceutical
Alliance (IPA) on April 13-14, 2026, at Federation House, FICCI, New Delhi.
The event will be inaugurated by Shri Jagat Prakash Nadda, Union Minister of Chemicals & Fertilizers,
and Smt. Anupriya Patel, Union Minister of State for Chemicals & Fertilizers. The conference serves as
a platform for sectoral growth and international collaboration, focusing on India’s pharmaceutical
capabilities, research and development (R&D), and the resilience of global supply chains.
The theme for this year’s edition is "Discover in India: Leapfrogging Life-Sciences Innovation."
Aligned with India’s vision of emerging as a global pharma innovation hub, the theme highlights the
transformative potential of life sciences in enhancing healthcare access, driving economic growth, andstrengthening global health systems. India continues to play a pivotal role in the global supply of
affordable, high-quality medicines. Building on this strong foundation, India Pharma 2026 aims to
accelerate the sector’s transition from a volume-driven model to a value- and innovation-led global
powerhouse.
The two-day event will witness the participation of a distinguished lineup of policymakers, industry
leaders, and domain experts from across the pharmaceutical sector. Prominent dignitaries include Shri
Manoj Joshi, Secretary, Department of Pharmaceuticals; Smt. Punya Salila Srivastava, Secretary,
Ministry of Health & Family Welfare; and Prof. Vinod K. Paul, Member, NITI Aayog. The event will
also feature eminent domain experts such as Dr. Renu Swarup, Former Secretary, Department of
Biotechnology; and Dr. Shivkumar Kalyanaraman, CEO, Anusandhan National Research Foundation.
The regulatory perspective will be represented by Dr. Rajeev Singh Raghuvanshi, Drug Controller
General of India (DCGI), along with Dr. A. Visala, Joint Drugs Controller (India), CDSCO, and Mr.
Gregory Smith, Country Director (India), US FDA, bringing both domestic and global regulatory insights.
The industry will be represented by leading industrialists such as Mr. Dilip Shanghvi of Sun Pharma and
Mr. Pankaj Patel of Zydus Lifesciences, along with FICCI Pharma Committee leadership including Mr.
Arjun Juneja, COO, Mankind Pharma Ltd.; Mr. Achin Gupta, Managing Director & Global CEO, Cipla
Ltd.; Mr. Winselow Tucker, President and General Manager, Eli Lilly & Company (India); and Mr.
Kartik Rajendran, Managing Director, Abbott India.
Apart from a dedicated special session, Start-up Showcase, the two- day event will feature following six
plenary sessions:
Policy Thrust for Catalysing Innovation
Enabling Regulatory Ecosystem to Foster Innovation
Harnessing AI and Next-Gen Technologies for Disruptive Innovation
Unleashing India’s CRDMO Potential
Developing a Vibrant Pharma Financing Ecosystem
Reflections and Big Moves to Leapfrog Innovation
For more information about the 9th Edition of India Pharma 2026, visit: https://indiapharma.ficci.in/.
The Federation of Indian Chambers of Commerce and Industry (FICCI), established in 1927, is India’s
oldest and largest apex business organization. A non-government, not-for-profit body, FICCI represents
the voice of India’s business and industry, serving a diverse membership of over 2,50,000 companies,
including corporate entities and multinational firms, through its extensive network of regional chambers
across the country.
The Department of Pharmaceuticals under the Ministry of Chemicals and Fertilisers is supporting the
country’s pharmaceutical and medtech sector to drive innovation and Atma Nirbharta, with focused policy
interventions, infrastructure development & strengthened industry-academia partnerships, aligned with the
broader vision of Viksit Bharat 2047.
***
PC/PM
(Release ID: 2251112) Visitor Counter : 320
Read this release in: Urdu , ही , Marathi , Gujarati